| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0021 | 0.9 |